TCR2 Therapeutics Inc. (TCRR): Price and Financial Metrics
GET POWR RATINGS... FREE!
TCRR Stock Price Chart Interactive Chart >
TCRR Price/Volume Stats
| Current price | $1.45 | 52-week high | $3.88 |
| Prev. close | $1.40 | 52-week low | $0.82 |
| Day low | $1.41 | Volume | 160,454 |
| Day high | $1.52 | Avg. volume | 238,508 |
| 50-day MA | $1.19 | Dividend yield | N/A |
| 200-day MA | $2.13 | Market Cap | 56.05M |
TCR2 Therapeutics Inc. (TCRR) Company Bio
TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering T-cells for cancer therapy. The company offers cancer therapy, T-cell biology, Immunology and Molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded in May 2015 and is headquartered in Cambridge, MA.
Latest TCRR News From Around the Web
Below are the latest news stories about TCR2 THERAPEUTICS INC that investors may wish to consider to help them evaluate TCRR as an investment opportunity.
TCR² Therapeutics: Betting On A Solid ReversalThesisTCR² Therapeutics (TCRR) develops oncology drug candidates. The company's stock started selling off around last year's September timeframe, leaving TCR² with a 52-week high of $19,03 and a 52-week low of $2,06. The company trades well below cash value at this point. It has a market cap around $140 million, and had $206 million cash in hand at the end of Q2 2022. Whereas earlier reporting by the company had been perceived as very positive by the market, the sell-off starting in September 2021 may have been caused by a perceived efficacy discrepancy in success between malignant pleural/peritonea... |
TCRR Price Returns
| 1-mo | 45.17% |
| 3-mo | -2.03% |
| 6-mo | -55.38% |
| 1-year | -56.59% |
| 3-year | -90.12% |
| 5-year | N/A |
| YTD | 45.17% |
| 2022 | -78.57% |
| 2021 | -84.93% |
| 2020 | 116.60% |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...